Immunovant Inc
For the period ended Mar 31, 2025. Filed May 29, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 29, 2025
IMVT$35.15+15.1%Stored close · as of Nov 9, 2026
Opening this filing…